Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

81.

Delivery Models for High-Risk Older Patients: Back to the Future?

JAMA.
Powers BW, Milstein A, Jain SH.
| Jan 5, 2016
82.

Accurate concentration control of mitochondria and nucleoids.

Science.
Jajoo R, Jung Y, Huh D, Viana MP, Rafelski SM, Springer M, Paulsson J.
| Jan 8, 2016
83.

Transcriptional profiles of supragranular-enriched genes associate with corticocortical network architecture in the human brain.

Proc. Natl. Acad. Sci. U.S.A.
Krienen FM, Yeo BT, Ge T, Buckner RL, Sherwood CC.
| Jan 26, 2016
84.

The calcium sensor synaptotagmin 7 is required for synaptic facilitation.

Nature.
Jackman SL, Turecek J, Belinsky JE, Regehr WG.
| Jan 7, 2016
85.

Improving the Prediction of Preeclampsia.

N. Engl. J. Med.
Seely EW, Solomon CG.
| Jan 7, 2016
86.

Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.

N. Engl. J. Med.
Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, Hilfiker-Kleiner D, Kamiya CA, Mazzarotto F, Cook SA, Halder I, Prasad SK, Pisarcik J, Hanley-Yanez K, Alharethi R, Damp J, Hsich E, Elkayam U, Sheppard R, Kealey A, Alexis J, Ramani G, Safirstein J, Boehmer J, Pauly DF, Wittstein IS, Thohan V, Zucker MJ, Liu P, Gorcsan J, McNamara DM, Seidman CE, Seidman JG, Arany Z, McNamara DM.
| Jan 21, 2016
87.

High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.

Nature.
Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK.
| Jan 28, 2016
88.

Bacterial RNA polymerase can retain σ70 throughout transcription.

Proc. Natl. Acad. Sci. U.S.A.
Harden TT, Wells CD, Friedman LJ, Landick R, Hochschild A, Kondev J, Gelles J.
| Jan 19, 2016
89.

Multidrug evolutionary strategies to reverse antibiotic resistance.

Science.
Baym M, Stone LK, Kishony R.
| Jan 1, 2016
90.

In vivo gene editing in dystrophic mouse muscle and muscle stem cells.

Science.
Tabebordbar M, Zhu K, Cheng JK, Chew WL, Widrick JJ, Yan WX, Maesner C, Wu EY, Xiao R, Ran FA, Cong L, Zhang F, Vandenberghe LH, Church GM, Wagers AJ.
| Jan 22, 2016
91.

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.

Science.
Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Castellanos Rivera RM, Madhavan S, Pan X, Ran FA, Yan WX, Asokan A, Zhang F, Duan D, Gersbach CA.
| Jan 22, 2016
92.

Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification.

Proc. Natl. Acad. Sci. U.S.A.
Agarwal S, Loder S, Brownley C, Cholok D, Mangiavini L, Li J, Breuler C, Sung HH, Li S, Ranganathan K, Peterson J, Tompkins R, Herndon D, Xiao W, Jumlongras D, Olsen BR, Davis TA, Mishina Y, Schipani E, Levi B.
| Jan 19, 2016
94.

Reply to Davis: Nitric oxide regulates lymphatic contractions.

Proc. Natl. Acad. Sci. U.S.A.
Kunert C, Baish JW, Liao S, Padera TP, Munn LL.
| Jan 12, 2016
96.

Choosing Benefits while Balancing Risks.

N. Engl. J. Med.
Greene MF, Ecker JL.
| Dec 31, 2015
97.

A cell wall damage response mediated by a sensor kinase/response regulator pair enables beta-lactam tolerance.

Proc. Natl. Acad. Sci. U.S.A.
Dörr T, Alvarez L, Delgado F, Davis BM, Cava F, Waldor MK.
| Jan 12, 2016
98.

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Lancet.
Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, Crump DN, Davies SK, Dawnay A, Dobbs S, Fletcher G, Ford J, Godfrey K, Gunu R, Habib M, Hallett R, Herod J, Jenkins H, Karpinskyj C, Leeson S, Lewis SJ, Liston WR, Lopes A, Mould T, Murdoch J, Oram D, Rabideau DJ, Reynolds K, Scott I, Seif MW, Sharma A, Singh N, Taylor J, Warburton F, Widschwendter M, Williamson K, Woolas R, Fallowfield L, McGuire AJ, Campbell S, Parmar M, Skates SJ.
| Dec 17, 2015
99.

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Lancet.
Yao JC, Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, Pacaud LB, Rouyrre N, Sachs C, Valle JW, Fave GD, Van Cutsem E, Tesselaar M, Shimada Y, Oh DY, Strosberg J, Kulke MH, Pavel ME.
| Dec 15, 2015
100.

Insulator dysfunction and oncogene activation in IDH mutant gliomas.

Nature.
Flavahan WA, Drier Y, Liau BB, Gillespie SM, Venteicher AS, Stemmer-Rachamimov AO, Suvà ML, Bernstein BE.
| Jan 7, 2016